All qPCR, western blotting, and immunohistochemistry results confirmed higher U2AF2 expressions in glioma tissues than in normal brain tissues, with the highest expression in WHO grade IV gliomas (Fig. 7c, d, f). This evidence concerns the gene U2AF2 and glioma.